EUVIMEDEUVIMED entdecken
Open Access

Enhanced cancer cell proliferation and aggressive phenotype counterbalance in breast cancer with high BRCA1 gene expression

Kohei Chida, Masanori Oshi, Arya Mariam Roy, Takumi Sato, Maya Penelope Takabe, Li Yan, Itaru Endo, Kenichi Hakamada, Kazuaki Takabe

Breast Cancer Research and Treatment · 2024

DOI: 10.1007/s10549-024-07421-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2024. Verfasst von Kohei Chida und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY, 14263, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, BRCA1 Protein, Cell Proliferation, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, U.S. Department of Defense, Rotary District 2830.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: While comprehensive research exists on the mutation of the DNA repair gene BRCA1, limited information is available regarding the clinical significance of BRCA1 gene expression. Given that cancer cell proliferation is aggrevated by DNA repair, we hypothesized that high BRCA1 gene expression breast cancer (BC) might be linked with aggressive tumor biology and poor clinical outcomes. METHODS: The cohorts: The Cancer Genome Atlas (TCGA, n = 1069), METABRIC (n = 1903), and SCAN-B (n = 3273) were utilzed to obtain data of 6245 BC patients. RESULTS: BC patients without BRCA1 mutation exhibited higher BRCA1 expression, which was associated with DNA repair functionality. However, no such correlation was observed with BRCA2 expression. The association of high BRCA1 expression with cancer cell proliferation was evidenced by significant enrichment of cell proliferation-related gene sets, higher histological grade, and proliferation score. Furthermore, increased levels of homologous recombination deficiency, intratumoral heterogeneity, and altered fractions were associated with high BRCA1 expression. Moreover, BC with high BRCA1 expression exhibited reduced infiltration of dendritic cells and CD8 T-cells, while showing increased infiltration of Th1 cells. Surprisingly, BRCA1 expression was not associated with the survival of BC irrespective of the subtypes. Conversely, BC with low BRCA1 expression enriched cancer aggravating pathway gene sets, such as Cancer Stem Cell-related signaling (NOTCH and HEDGEHOG), Angiogenesis, Epithelial-Mesenchymal Transition, Inflammatory Response, and TGF-beta signaling. CONCLUSION: Despite being linked to heightened proliferation of cancer cells and unassertive phenotype, BRCA1 expression did not show any association with survival in BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBRCA1 ProteinCell ProliferationGene Expression Regulation, NeoplasticPhenotypeHumansFemalePrognosisBiomarkers, TumorMutationDNA RepairGene Expression Profiling

Stichwörter der Autor:innen

BRCA1Breast cancerDNA repair genesGene expressionSignalingTranscriptome

Substanzen

BRCA1 ProteinBRCA1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY, 14263, USA.
  • Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, 036-8562, Japan.
  • Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, 236-0004, Japan.
  • Department of Hematology and Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.
  • Department of Medical Science, The University of Tokyo, Tokyo, 113-8654, Japan.
  • Department of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.

Förderung

  • NCI NIH HHS
  • U.S. Department of Defense
  • Rotary District 2830
  • NIBIB NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Chida, K., Oshi, M., Roy, A. M., Sato, T., Takabe, M. P., Yan, L., Endo, I., Hakamada, K., & Takabe, K. (2024). Enhanced cancer cell proliferation and aggressive phenotype counterbalance in breast cancer with high BRCA1 gene expression. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07421-8

Vancouver

Chida K, Oshi M, Roy AM, Sato T, Takabe MP, Yan L, et al. Enhanced cancer cell proliferation and aggressive phenotype counterbalance in breast cancer with high BRCA1 gene expression. Breast Cancer Research and Treatment. 2024. doi:10.1007/s10549-024-07421-8

BibTeX
@article{Chida2024,
  author = {Chida, Kohei and Oshi, Masanori and Roy, Arya Mariam and Sato, Takumi and Takabe, Maya Penelope and Yan, Li and Endo, Itaru and Hakamada, Kenichi and Takabe, Kazuaki},
  title = {Enhanced cancer cell proliferation and aggressive phenotype counterbalance in breast cancer with high BRCA1 gene expression},
  journal = {Breast Cancer Research and Treatment},
  year = {2024},
  doi = {10.1007/s10549-024-07421-8}
}
Kostenlos starten →